Abstract:The administration of therapeutic drugs through dermal routes, such as creams and ointments, has emerged as an increasingly popular alternative to traditional delivery methods, such as tablets and injections. In the context of drug development, it is crucial to identify the optimal doses and delivery routes that ensure successful outcomes. Physiologically based pharmacokinetic (PBPK) models have been proposed to simulate drug delivery and optimize drug formulations, but the calibration of these models is challenging due to the multitude of variables involved and limited experimental data. One significant research gap that this article addresses is the need for more efficient and accurate methods for calibrating PBPK models for dermal drug delivery. This manuscript presents a novel approach and an integrated dermal drug delivery model to address this gap that leverages virtual in vitro release (IVRT) and permeation (IVPT) testing data to optimize mechanistic models. The proposed approach was demonstrated through a study involving Desoximetasone cream and ointment formulations, where the release kinetics and permeation profiles of Desoximetasone were determined experimentally, and a computational model was created to simulate the results. The experimental studies showed that, even though the cumulative permeation of Desoximetasone at the end of the permeation study was comparable, there was a significant difference seen in the lag time in the permeation of Desoximetasone between the cream and ointment. Additionally, there was a significant difference seen in the amount of Desoximetasone permeated through human cadaver skin at early time points when the cream and ointment were compared. The computational model was optimized and validated, suggesting that this approach has the potential to bridge the existing research gap by improving the accuracy and efficiency of drug development processes. The model results show a good fit between the experimental data and model predictions. During the model optimization process, it became evident that there was variability in both the permeability and the partition coefficient within the stratum corneum. This variability had a significant and noteworthy influence on the overall performance of the model, especially when it came to its capacity to differentiate between cream and ointment formulations. Leveraging virtual models significantly aids the comprehension of drug release and permeation, mitigating the demanding data requirements. The use of virtual IVRT and IVPT data can accelerate the calibration of PBPK models, streamline the selection of the appropriate doses, and optimize drug delivery. Moreover, this novel approach could potentially reduce the time and resources involved in drug development, thus making it more cost-effective and efficient.

Topical Bioequivalence of Acyclovir Creams Using Dermal Microdialysis in Pigs: A New Model to Evaluate Bioequivalence for Topical Formulations

Establishment of an animal model of dermatophytosis and evaluation of the antifungal efficacy on dermatophytosis with this model

Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams

Feasibility of Enhancing Skin Permeability of Acyclovir through Sterile Topical Lyophilized Wafer on Self-Dissolving Microneedle-Treated Skin

Combined use of bile acids and aminoacids to improve permeation properties of acyclovir

Study of Relative Bioavailability of Aciclovir Tablet in Healthy Volunteers

Physiologically‐based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%

Study on relative bioavailability of acyclovir tablets in healthy volunteers

Bioequivalence of Valaciclovir Capsules in Human

Development of Mucoadhesive Microspheres of Acyclovir with Enhanced Bioavailability.

Modification of the conformational skin structure by treatment with liposomal formulations and its correlation to the penetration depth of aciclovir

Pharmacokinetics and Relative Bioavailability Study of Valaciclovir Hydrochloride Tablets in Chinese Healthy Volunteers

Formulation and optimization of microsponge-loaded emulgel to improve the transdermal application of acyclovir—a DOE based approach

Equivalence assessment of creams with quali-quantitative differences in light of the EMA and FDA regulatory framework

Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis

Pharmacokinetics and Bioequivalence Evaluation of Two Acipimox Tablets: A Single-Dose, Randomized-Sequence, Two-Way Crossover Study in Healthy Chinese Male Volunteers

Qualitative and quantitative analysis of Arnebiae Radix and Dictamni Cortex and efficacy study of herbal extracts on allergic contact dermatitis using 3D human reconstructed epidermis

Influence of type of vehicle on dermal penetration efficacy of hydrophilic, amphiphilic, lipophilic model drugs

Topical Delivery of Diacetyl Boldine in a Microemulsion Formulation for Chemoprotection against Melanoma

A Comparative Evaluation of Desoximetasone Cream and Ointment Formulations Using Experiments and In Silico Modeling

Determining topical product bioequivalence with stimulated Raman scattering microscopy